Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I'm still ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Considering taking supplements to treat beta thalassemia? Below is a list of common natural remedies used to treat or reduce the symptoms of beta thalassemia. Follow the links to read common uses ...

Non-transfusion-dependent thalassemia encompasses three clinically distinct forms -- beta-thalassaemia intermedia, hemoglobin E/beta-thalassaemia (mild and moderate forms), and al ...

Discover the latest addition to Children's Hospital Los Angeles' 10 cell and gene therapy treatments, including Casgevy for sickle cell disease ...

The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of high-quality ... and Medicine will develop a strategic plan and blueprint for addressing ...

There were no serious adverse events or treatment-related mortalities. Evidence Rating Level: 2 (Good) Study Rundown: Transfusion-dependent β-thalassemia (TDT) is a condition that results in iron ...

remaining considerate of the populations that will ultimately be the end-users and testament to the technology’s success is vital. Diagnosed with beta-thalassemia at six months old, Amar has had ...

Thalassemia is a rare ... AGIO closed Tuesday's (Jan. 07, 2025) trading at $35.12, up 4.71 %. In Premarket trading, the stock is up another 0.77% at $35.39 Agios Pharmaceuticals NewsMORE Related ...